Literature DB >> 32418065

Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever.

Christel H Kamani1, Mario Jreige1, Martin Pappon1, Arnaud Fischbacher2, Olivier Borens2, Pierre Monney3, Marie Nicod Lalonde1, Niklaus Schaefer1, John O Prior4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32418065      PMCID: PMC7229432          DOI: 10.1007/s00259-020-04860-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
A 75-year-old diabetic man with a cardiac history of pacemaker implantation and mechanical prosthetic valve (PV) replacement, also known for chronic osteitis of the first left metatarsophalangeal joint (MTP I), was treated with oral antibiotic on an outpatient basis with poor compliance when he developed intermittent fever (39.8 °C) and left foot pain. Laboratory testing revealed a slight elevation of the white blood cell count (10.7 G/L) and a significant elevation of the C-reactive protein (235 mg/L). Hemocultures turned positive for multi-sensitive Staphylococcus aureus and Proteus mirabilis. A left foot CT showed MTP I osteoarthritis without collection. Transoesophageal echocardiography (TOE) showed no evidence of endocarditis. A double antibiotic regimen was started, but the patient developed persistent fever. Repeated TOE raised endocarditis suspicion. Because of a newly developed cough, a search for respiratory pathogens was performed and turned positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. An 18F-FDG PET/CT was requested for investigating the suspicion of PV infection with a 72-h low-carbohydrate diet preparation. The 18F-FDG PET maximum-intensity projection image shows (a) bilateral metabolic lung lesions, the foot infection (*), and one metabolically active draining sentinel lymph node (arrowhead). (b) Free-breathing lung CT and 18F-FDG with hypermetabolic (SUVmax 7.6 g/mL) focal ground-glass opacities with partial consolidation and mild bronchial dilatation with a peripheral distribution in the subpleural and periscissural regions of the apical and posterior segments of both upper lobes and right middle lobe, as previously described on CT [1]. (c) Hypermetabolic lymphadenopathies in the right lower paratracheal, subcarinal, and bilateral hilar stations (SUVmax 6.1 g/mL). (d, e) Absence of active PV or PM case/lead infection and no sign of septic embolism. (f) 18F-FDG PET/CT showing intense FDG accumulation in MTP I compatible with an active bone infection. (g) Comparison of 18F-FDG activity in the lung ground-glass opacities vs. the mediastinal, hilar, and paratracheal lymph nodes. This case illustrates the benefit of 18F-FDG PET/CT in differential diagnosis of fever of multiple possible origins in the setting of SARS-CoV-2 infection [2]. In accordance with previous retrospective observations [3, 4], we confirmed the characteristic pattern of SARS-CoV-2 viral infection on 18F-FDG PET/CT with intense 18F-FDG uptake of pulmonary lesions, nodal involvement, and absence of other hypermetabolic lesions [3]. To the best of our knowledge, this is the first prospective case showing the feasibility of 18F-FDG PET/CT in patients with confirmed SARS-CoV-2 infection when taking adequate protective measures [5].
  5 in total

1.  Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.

Authors:  Xi Xu; Chengcheng Yu; Jing Qu; Lieguang Zhang; Songfeng Jiang; Deyang Huang; Bihua Chen; Zhiping Zhang; Wanhua Guan; Zhoukun Ling; Rui Jiang; Tianli Hu; Yan Ding; Lin Lin; Qingxin Gan; Liangping Luo; Xiaoping Tang; Jinxin Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-28       Impact factor: 9.236

2.  FDG PET/CT of COVID-19.

Authors:  Sijuan Zou; Xiaohua Zhu
Journal:  Radiology       Date:  2020-03-06       Impact factor: 11.105

3.  The potential added value of FDG PET/CT for COVID-19 pneumonia.

Authors:  Yan Deng; Lei Lei; Yue Chen; Wei Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-21       Impact factor: 9.236

4.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases.

Authors:  Chunxia Qin; Fang Liu; Tzu-Chen Yen; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-22       Impact factor: 9.236

5.  Suggestions for safety and protection control in Department of Nuclear Medicine during the outbreak of COVID-19.

Authors:  Xiao Zhang; Fuqiang Shao; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-25       Impact factor: 10.057

  5 in total
  8 in total

Review 1.  FDG-PET/CT images of COVID-19: a comprehensive review.

Authors:  Ryogo Minamimoto; Masatoshi Hotta; Masahiro Ishikane; Takeshi Inagaki
Journal:  Glob Health Med       Date:  2020-08-31

Review 2.  Global research trends in COVID-19 with MRI and PET/CT: a scoping review with bibliometric and network analyses.

Authors:  Nathaly Rivera-Sotelo; Raul-Gabriel Vargas-Del-Angel; Sergey K Ternovoy; Ernesto Roldan-Valadez
Journal:  Clin Transl Imaging       Date:  2021-08-14

Review 3.  Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review.

Authors:  Tianbao Li; Tao Huang; Cheng Guo; Ailan Wang; Xiaoli Shi; Xiaofei Mo; Qingqing Lu; Jing Sun; Tingting Hui; Geng Tian; Leyi Wang; Jialiang Yang
Journal:  Innovation (Camb)       Date:  2021-05-11

4.  Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019.

Authors:  Freimut D Juengling; Antonio Maldonado; Frank Wuest; Thomas H Schindler
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 5.  Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review.

Authors:  Salvatore Annunziata; Roberto C Delgado Bolton; Christel-Hermann Kamani; John O Prior; Domenico Albano; Francesco Bertagna; Giorgio Treglia
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-10

6.  Positron-emission tomography-computed tomography appearance of COVID-19 infection.

Authors:  Arjun Padmanabhan; Nishal Neeloth; Gopinath Rijju
Journal:  Lung India       Date:  2022 Mar-Apr

7.  Asymptomatic COVID-19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring.

Authors:  Andra Piciu; Simona Manole; Doina Piciu; Teodora Dreve; Andrei Roman
Journal:  Med Pharm Rep       Date:  2021-01-29

Review 8.  Imaging of Hematological Patients in the Era of COVID-19.

Authors:  Yael Eshet; Abraham Avigdor; Meirav Kedmi; Noam Tau
Journal:  Acta Haematol       Date:  2022-01-31       Impact factor: 3.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.